Tasmar
Brand for: Tolcapone
My Prescription
Payment
Select pharmacy
$1,039.65
Print or send this coupon to your phone
WalgreensPowered byAbout Tasmar
Drug Details
Tolcapone, marketed as Tasmar, is an oral medication used to enhance the treatment of Parkinson's disease, particularly when carbidopa/levodopa alone is insufficient in controlling symptoms. It belongs to a category of drugs known as COMT inhibitors. By blocking the enzyme catechol-O-methyltransferase (COMT), tolcapone helps maintain stable levels of levodopa in the body. This action extends the duration of levodopa's effects, reducing the likelihood of symptoms returning or worsening between doses. Always consult your healthcare provider for advice tailored to your specific medical needs.
Tasmar (Tolcapone) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100MG | 90 Tablets | $1,910.60 | $21.23 |
Tasmar FAQs
Tasmar is used as an adjunct treatment for patients with Parkinson's disease. It is specifically prescribed to help manage symptoms in individuals who are experiencing fluctuations in the effectiveness of their primary Parkinson's medication, levodopa/carbidopa. Tasmar works by inhibiting the enzyme catechol-O-methyltransferase (COMT), which helps to prolong the effect of levodopa.
Tasmar (tolcapone) can cause several side effects. Common side effects include nausea, diarrhea, dizziness, drowsiness, and dry mouth. More serious side effects may include liver damage, which requires regular monitoring of liver function tests, and symptoms such as jaundice, dark urine, or severe abdominal pain should be reported immediately. Other serious side effects can include confusion, hallucinations, and muscle stiffness. It is important for patients to discuss any side effects with their healthcare provider.
Tolcapone is classified as a catechol-O-methyltransferase (COMT) inhibitor.
Tolcapone is effective in treating Parkinson's disease by inhibiting the enzyme catechol-O-methyltransferase (COMT). This action prevents the breakdown of levodopa, a precursor to dopamine, thereby increasing its availability in the brain. As a result, tolcapone helps to enhance and prolong the effects of levodopa therapy, improving motor symptoms in patients with Parkinson's disease. However, due to potential liver toxicity, its use requires careful monitoring of liver function.
Tasmar is classified as a catechol-O-methyltransferase (COMT) inhibitor. It is used in the management of Parkinson's disease to help increase the effectiveness of levodopa/carbidopa therapy.